oral glp 1 medications GLP-1 Medications: Everything You Need to Know Oral GLP-1: how to win

As regulatory agencies continue to monitor the safety and efficacy of these medications, the GLP-1 market is expected to grow significantly, potentially reaching $50 billion annually by 2030

waiting for prior authorization Neither choice is "wrong"-they're different regulatory frameworks with different trade-offs

News-Medical+3EurekAlert!+3ASMBS+3 To put numbers on it: Surgical patients lost ~58 lbs in two years ( 24% of total body weight, or TBW) GLP-1 patients lost only ~12 lbs ( 4.7% TBW) over the same period EurekAlert!+2News-Medical+2 Even among GLP-1 users who continued therapy for a full year, weight loss averaged only ~7% TBWstill far less than surgical outcomes EurekAlert!+2ASMBS+2 Another rigorous analysis published in JAMA Surgery compared weight loss surgery and GLP-1 receptor agonists over two years

After propensity score matching, the analytic cohort comprised 26,408 matched patients: 13,204 users and 13,204 non-users

Other drugs on the market such as Mounjaro (tirzepatide), which was approved for treating Type 2 diabetes but also seems to help with weight loss, could also see greater interest